查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2136688

大麻二酚 (CBD) 分離物市場：全球市場預測，2026-2032 年

Cannabidiol Isolates Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，大麻二酚 (CBD) 分離物市場將成長至 153.5 億美元，複合年成長率為 10.06%。

主要市場統計數據
基準年 2025 78.4億美元
預計年份：2026年 84億美元
預測年份 2032 153.5億美元
複合年成長率 (%) 10.06%

大麻二酚 (CBD) 分離物：概述

大麻二酚 (CBD)隔離群是一種高度純化的配方，主要成分為 CBD，通常不含全光譜或頻譜產品中常見的多種大麻素和萜烯類化合物。其優勢在於配方設計的柔軟性、成分的標準化以及開發不含其他可檢測大麻素的產品的能力。市場發展取決於監管分類、分析檢驗、產品品質、允許用途以及消費者和行業的接受度。

監管和配方變化正在重新定義大麻二酚 (CBD)隔離群。

產業趨勢正朝著更嚴格的監管方向發展，包括成分識別、污染物限量、標籤、可追溯性和功效聲明等方面。生產商和下游配方開發人員越來越需要提供可證明的原料來源、檢驗的測試數據、穩定性數據，並明確區分化妝品、食品、保健品、藥品和工業應用。配方創新也不斷進步，發展方向包括提高分散性、開發飲料和外用製劑，以及設計針對CBD水溶性有限的劑型。

人工智慧可以提高品管和商業性執行效率。

人工智慧可以透過識別配方模式、最佳化輔料選擇、檢測實驗室和生產數據中的異常情況以及改進需求和庫存計劃，為大麻二酚隔離群業務運營提供支援。機器學習工具還可用於文件審核、監控監管趨勢、客戶細分和預測性維護。為了充分發揮這些優勢，具有代表性的資料集、人工監督、檢驗的模型以及用於防止未經證實的健康益處聲明和錯誤批次放行決策的控制系統至關重要。

大麻二酚 (CBD)隔離群市場的區域趨勢

在北美，不斷發展的聯邦和地方政府法規、完善的成分檢測能力以及對標準化健康和個人護理配方的需求正在塑造市場格局。在歐洲，挑戰包括安全文件、新型食品和產品特定要求、可追溯性以及跨司法管轄區的監管協調。亞太地區擁有先進的製造和研發能力，但各國法規各不相同，且對功能性產品、化妝品和藥品應用領域的興趣日益濃厚。拉丁美洲的特點是監管發展、農業潛力以及對受監管的大麻素應用日益成長的興趣方面存在差異。在中東，必須特別注意有關受管制物質的法規、進口程序以及宗教和產品合規性的考量。在非洲，種植和加工能力方面的機會顯而易見，但基礎設施、監管清晰度和檢測實驗室的可及性仍然是至關重要的商業條件。

集團層級趨勢：東協、金磚國家、歐盟、七國集團、海灣合作理事會、北約

在東協市場，各國對大麻、CBD、食品、化妝品和藥品的監管差異顯著，需要進行國別評估。金磚國家雖然擁有強大的農業、製造業和研發能力，但各國的許可和進口要求各不相同。歐盟在產品安全和市場進入方面遵循通用原則，但具體實施方式和產品分類可能因國家而異。七國集團（G7）國家普遍重視分析驗證、消費者保護和正式的合規機制。在海灣合作理事會（GCC）市場，必須仔細考慮允許使用的成分、進口限制和文化因素。由於北約成員國之間沒有統一的CBD管理體制，相關的商業決策將遵循各成員國的國家框架。

優先市場中的國家特定考慮因素

澳洲和加拿大維持著系統化的監管流程，但對食品、治療、化妝品和工業用途等進行了嚴格區分。美國在聯邦、州和產品類型層面仍然高度分散。巴西、墨西哥、印度、中國、日本、韓國、俄羅斯、法國、德國、義大利、西班牙和英國分別要求對種植、提取、進口、標籤、大麻素閾值和允許的功效聲明進行單獨審查。在歐洲，儘管有區域協調，但各國執法和產品分類仍會對商業化產生重大影響。在所有上述國家，產品上市前，諮詢當地法律顧問、進行認可的檢測以及建立完善的供應鏈管理至關重要。

大麻二酚隔離群應用領導者指南

經營團隊在選擇目標市場或做出功效聲明之前，必須建立針對特定產品的監管體系。他們還應透過成分鑑定、純度、殘留溶劑、農藥、重金屬、微生物和穩定性測試來評估供應商合格，保持批間可追溯性，並根據需要利用獨立的檢測實驗室。製劑研發團隊應根據已驗證的性能而非行銷術語來選擇給藥系統。此外，公司應投資於管治流程，以確保合規性、不利事件監測、員工培訓、品質數據的網路安全以及對人工智慧輸出的科學和監管審查。

調查方法執行摘要

本執行摘要涵蓋「大麻二酚 (CBD) 分離物」這個市場類別，並從產品特性、法規、配方、技術、地區和營運要求等方面對研究結果進行梳理。本評估基於定性分析和證據，並遵循大麻素產品合規性、分析測試、供應鏈管理和人工智慧 (AI)管治方面廣泛認可的原則。本摘要刻意省略了市場規模估算與預測、市場規模計算、市佔率、預測、公司間觀察。在做出任何商業性決策之前，應根據現行法規、監管指南和進口法規檢驗相關國家和地區的情況。

結論：合規性和證據是實現永續發展的關鍵。

大麻二酚 (CBD)隔離群為配方開發人員提供了一種標準化的原料，適用於需要控制大麻素成分的產品，但商業性可行性並非僅取決於原料的純度。監管分類、嚴格的測試、透明的採購、負責任的標籤以及特定應用領域的證據決定了哪些商機能夠得到永續開發。將嚴謹的品管系統、有針對性的配方研發以及精心管理的人工智慧相結合的行業領導者，將能夠在碎片化且瞬息萬變的國際環境中游刃有餘。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章：大麻二酚 (CBD) 分離物市場：依形式分類

  • 膠囊
  • 油
  • 粉末
  • 外用

第8章：大麻二酚 (CBD) 分離物市場：按應用領域分類

  • 化妝品
  • 食品/飲料
  • 營養保健品
  • 寵物用品
  • 製藥

第9章：大麻二酚 (CBD) 分離物市場：依分銷管道分類

  • 線上
  • 藥局
  • 專賣店
  • 超級市場

第10章：大麻二酚 (CBD) 分離物市場：按最終用戶分類

  • 人類
  • 寵物

第11章：大麻二酚 (CBD) 分離物市場：以萃取方法分類

  • 二氧化碳萃取方法
  • 溶劑萃取
  • 蒸汽蒸餾

第12章：大麻二酚 (CBD) 分離物市場：按地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第13章：大麻二酚 (CBD) 分離物市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 大麻二酚 (CBD) 分離物市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 2025年市佔率分析
  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第16章：公司簡介

  • Amyris, Inc.
  • Aurora Cannabis Inc.
  • Canopy Growth Corporation
  • Charlotte's Web Holdings, Inc.
  • Cronos Group Inc.
  • CV Sciences, Inc.
  • Folium Biosciences LLC
  • Isodiol International Inc.
  • Mile High Labs LLC
  • Xinergy Ltd

第17章 主要專家

Product Code: MRR-961F26FD7DC6

The Cannabidiol Isolates Market is projected to grow by USD 15.35 billion at a CAGR of 10.06% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 7.84 billion
Estimated Year [2026] USD 8.40 billion
Forecast Year [2032] USD 15.35 billion
CAGR (%) 10.06%

Cannabidiol Isolates: Executive Overview

Cannabidiol (CBD) isolates are highly purified preparations containing CBD as the principal cannabinoid, typically without the broader cannabinoid and terpene profile found in full-spectrum or broad-spectrum products. Their appeal is linked to formulation flexibility, standardized composition, and the ability to develop products without detectable levels of other cannabinoids. Market development depends on regulatory classification, analytical verification, product quality, permitted applications, and consumer or industrial acceptance.

Regulatory and Formulation Shifts Reshape Cannabidiol Isolates

The landscape is shifting toward stronger controls over ingredient identity, contaminant limits, labeling, traceability, and claims. Producers and downstream formulators increasingly need documented sourcing, validated testing, stability data, and clear distinction between cosmetic, food, wellness, pharmaceutical, and industrial uses. Formulation innovation is also moving toward improved dispersion, incorporation into beverages and topical systems, and delivery formats designed to address CBD's limited water solubility.

Artificial Intelligence Strengthens Quality and Commercial Execution

Artificial intelligence can support cannabidiol-isolate operations by identifying formulation patterns, optimizing excipient selection, detecting anomalies in laboratory and manufacturing data, and improving demand or inventory planning. Machine-learning tools may also assist document review, regulatory monitoring, customer segmentation, and predictive maintenance. These benefits depend on representative datasets, human oversight, validated models, and controls that prevent unsupported health claims or erroneous batch-release decisions.

Regional Insights Across the Cannabidiol-Isolate Landscape

North America is shaped by evolving federal and subnational rules, established ingredient testing capabilities, and demand for standardized wellness and personal-care formulations. Europe emphasizes safety documentation, novel-food or product-specific requirements, traceability, and harmonization challenges across jurisdictions. Asia-Pacific combines advanced manufacturing and research capabilities with diverse national rules and growing interest in functional, cosmetic, and pharmaceutical applications. Latin America is characterized by uneven regulatory development, agricultural potential, and expanding interest in regulated cannabinoid uses. The Middle East generally requires particularly careful attention to controlled-substance rules, import procedures, and religious or product-compliance considerations. Africa presents opportunities linked to cultivation and processing capabilities, while infrastructure, regulatory clarity, and laboratory access remain important operating conditions.

Group-Level Dynamics: ASEAN, BRICS, EU, G7, GCC, and NATO

ASEAN markets require country-by-country assessment because rules on hemp, CBD, food, cosmetics, and medicines differ substantially. BRICS economies combine significant agricultural, manufacturing, and research capabilities with varied licensing and import requirements. The European Union is influenced by shared principles on product safety and market access, although national implementation and product classification can differ. G7 economies generally place strong emphasis on analytical validation, consumer protection, and formal compliance systems. GCC markets require close review of permitted ingredients, import controls, and cultural considerations. NATO membership does not create a unified CBD regime, so relevant commercial decisions remain subject to each member's national framework.

Country-Level Considerations for Priority Markets

Australia and Canada maintain structured regulatory pathways but distinguish carefully among food, therapeutic, cosmetic, and industrial uses. The United States remains highly fragmented across federal, state, and product categories. Brazil, Mexico, India, China, Japan, South Korea, Russia, France, Germany, Italy, Spain, and the United Kingdom each require specific review of cultivation, extraction, importation, labeling, cannabinoid thresholds, and allowable claims. Within Europe, national enforcement and product classification can materially affect commercialization despite regional coordination. Across all listed countries, local legal counsel, accredited testing, and documented supply-chain controls are essential before launch.

Actions for Leaders in Cannabidiol-Isolate Applications

Leaders should establish a product-by-product regulatory matrix before selecting target markets or making claims. They should qualify suppliers through identity, purity, residual-solvent, pesticide, heavy-metal, microbiological, and stability testing; maintain batch-level traceability; and use independent laboratories where appropriate. Formulation teams should select delivery systems based on verified performance rather than marketing language. Companies should also invest in compliant labeling, adverse-event monitoring, employee training, cybersecurity for quality data, and governance processes that require scientific and regulatory review of artificial-intelligence outputs.

Research Methodology for the Executive Summary

This executive summary uses the supplied market category, cannabidiol isolates, as its scope and organizes findings around product characteristics, regulation, formulation, technology, geography, and operating requirements. The assessment is qualitative and evidence-oriented: it relies on broadly established principles of cannabinoid product compliance, analytical testing, supply-chain management, and artificial-intelligence governance. It intentionally excludes market estimates, market sizing, market shares, forecasts, and company-specific comparisons. Country and regional observations should be validated against current statutes, agency guidance, and import rules before commercial decisions are made.

Conclusion: Compliance and Evidence Define Sustainable Progress

Cannabidiol isolates offer formulators a standardized input for products requiring controlled cannabinoid composition, but commercial viability depends on more than ingredient purity. Regulatory classification, defensible testing, transparent sourcing, responsible claims, and application-specific evidence will determine which opportunities can be developed sustainably. Industry leaders that combine disciplined quality systems with targeted formulation research and carefully governed artificial intelligence will be better positioned to navigate a fragmented and evolving international environment.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. New Revenue Opportunities
  • 3.4. Next-Generation Business Models
  • 3.5. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Cannabidiol Isolates Market, by Form

  • 7.1. Introduction
  • 7.2. Capsule
  • 7.3. Oil
  • 7.4. Powder
  • 7.5. Topical

8. Cannabidiol Isolates Market, by Application

  • 8.1. Introduction
  • 8.2. Cosmetic
  • 8.3. Food Beverage
  • 8.4. Nutraceutical
  • 8.5. Pet Products
  • 8.6. Pharmaceutical

9. Cannabidiol Isolates Market, by Distribution Channel

  • 9.1. Introduction
  • 9.2. Online
  • 9.3. Pharmacies
  • 9.4. Specialty Stores
  • 9.5. Supermarkets

10. Cannabidiol Isolates Market, by End User

  • 10.1. Introduction
  • 10.2. Humans
  • 10.3. Pets

11. Cannabidiol Isolates Market, by Extraction Method

  • 11.1. Introduction
  • 11.2. Co2 Extraction
  • 11.3. Solvent Extraction
  • 11.4. Steam Distillation

12. Cannabidiol Isolates Market, by Region

  • 12.1. Introduction
  • 12.2. Asia-Pacific
  • 12.3. North America
  • 12.4. Latin America
  • 12.5. Europe
  • 12.6. Middle East
  • 12.7. Africa

13. Cannabidiol Isolates Market, by Group

  • 13.1. Introduction
  • 13.2. ASEAN
  • 13.3. GCC
  • 13.4. European Union
  • 13.5. BRICS
  • 13.6. G7
  • 13.7. NATO

14. Cannabidiol Isolates Market, by Country

  • 14.1. Introduction
  • 14.2. United States
  • 14.3. Canada
  • 14.4. Mexico
  • 14.5. Brazil
  • 14.6. United Kingdom
  • 14.7. Germany
  • 14.8. France
  • 14.9. Russia
  • 14.10. Italy
  • 14.11. Spain
  • 14.12. China
  • 14.13. India
  • 14.14. Japan
  • 14.15. Australia
  • 14.16. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2025
  • 15.2. Market Concentration Analysis, 2025
    • 15.2.1. Concentration Ratio (CR)
    • 15.2.2. Herfindahl Hirschman Index (HHI)
  • 15.3. Recent Developments & Impact Analysis, 2025
  • 15.4. Product Portfolio Analysis, 2025
  • 15.5. Benchmarking Analysis, 2025

16. Company Profiles

  • 16.1. Amyris, Inc.
  • 16.2. Aurora Cannabis Inc.
  • 16.3. Canopy Growth Corporation
  • 16.4. Charlotte's Web Holdings, Inc.
  • 16.5. Cronos Group Inc.
  • 16.6. CV Sciences, Inc.
  • 16.7. Folium Biosciences LLC
  • 16.8. Isodiol International Inc.
  • 16.9. Mile High Labs LLC
  • 16.10. Xinergy Ltd

17. Key Experts

LIST OF FIGURES

  • FIGURE 1. Global Cannabidiol Isolates Market, Years Considered for the Study
  • FIGURE 2. Global Cannabidiol Isolates Market, Research Design
  • FIGURE 3. Global Cannabidiol Isolates Market, Research Framework
  • FIGURE 4. Global Cannabidiol Isolates Market, Data Triangulation
  • FIGURE 5. Global Cannabidiol Isolates Market Size, 2017-2032 (USD Million)
  • FIGURE 6. Global Cannabidiol Isolates Market Size, by Form, 2025 vs 2032 (%)
  • FIGURE 7. Global Cannabidiol Isolates Market Size, by Form, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 8. Global Cannabidiol Isolates Market Size, by Application, 2025 vs 2032 (%)
  • FIGURE 9. Global Cannabidiol Isolates Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 10. Global Cannabidiol Isolates Market Size, by Distribution Channel, 2025 vs 2032 (%)
  • FIGURE 11. Global Cannabidiol Isolates Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 12. Global Cannabidiol Isolates Market Size, by End User, 2025 vs 2032 (%)
  • FIGURE 13. Global Cannabidiol Isolates Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 14. Global Cannabidiol Isolates Market Size, by Extraction Method, 2025 vs 2032 (%)
  • FIGURE 15. Global Cannabidiol Isolates Market Size, by Extraction Method, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 16. Global Cannabidiol Isolates Market Size, by Region, 2025 vs 2032 (%)
  • FIGURE 17. Global Cannabidiol Isolates Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 18. Global Cannabidiol Isolates Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 19. Global Cannabidiol Isolates Market Size, by Country, 2025 vs 2032 (%)
  • FIGURE 20. Global Cannabidiol Isolates Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 21. Global Cannabidiol Isolates Market Share, by Key Player, 2025

LIST OF TABLES

  • TABLE 1. Global Cannabidiol Isolates Market Segmentation & Coverage
  • TABLE 2. Global Cannabidiol Isolates Market Size, 2017-2032 (USD Million)
  • TABLE 3. Global Cannabidiol Isolates Market Size, by Form, 2017-2032 (USD Million)
  • TABLE 4. Global Capsule Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 5. Global Capsule Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 6. Global Capsule Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 7. Global Oil Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 8. Global Oil Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 9. Global Oil Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 10. Global Powder Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 11. Global Powder Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 12. Global Powder Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 13. Global Topical Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 14. Global Topical Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 15. Global Topical Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 16. Global Cannabidiol Isolates Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 17. Global Cosmetic Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 18. Global Cosmetic Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 19. Global Cosmetic Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 20. Global Food Beverage Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 21. Global Food Beverage Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 22. Global Food Beverage Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 23. Global Nutraceutical Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 24. Global Nutraceutical Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 25. Global Nutraceutical Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 26. Global Pet Products Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 27. Global Pet Products Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 28. Global Pet Products Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 29. Global Pharmaceutical Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 30. Global Pharmaceutical Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 31. Global Pharmaceutical Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 32. Global Cannabidiol Isolates Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 33. Global Online Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 34. Global Online Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 35. Global Online Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 36. Global Pharmacies Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 37. Global Pharmacies Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 38. Global Pharmacies Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 39. Global Specialty Stores Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 40. Global Specialty Stores Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 41. Global Specialty Stores Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 42. Global Supermarkets Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 43. Global Supermarkets Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 44. Global Supermarkets Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 45. Global Cannabidiol Isolates Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 46. Global Humans Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 47. Global Humans Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 48. Global Humans Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 49. Global Pets Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 50. Global Pets Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 51. Global Pets Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 52. Global Cannabidiol Isolates Market Size, by Extraction Method, 2017-2032 (USD Million)
  • TABLE 53. Global Co2 Extraction Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 54. Global Co2 Extraction Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 55. Global Co2 Extraction Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 56. Global Solvent Extraction Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 57. Global Solvent Extraction Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 58. Global Solvent Extraction Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 59. Global Steam Distillation Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 60. Global Steam Distillation Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 61. Global Steam Distillation Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 62. Global Cannabidiol Isolates Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 63. Asia-Pacific Cannabidiol Isolates Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 64. Asia-Pacific Cannabidiol Isolates Market Size, by Form, 2017-2032 (USD Million)
  • TABLE 65. Asia-Pacific Cannabidiol Isolates Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 66. Asia-Pacific Cannabidiol Isolates Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 67. Asia-Pacific Cannabidiol Isolates Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 68. Asia-Pacific Cannabidiol Isolates Market Size, by Extraction Method, 2017-2032 (USD Million)
  • TABLE 69. North America Cannabidiol Isolates Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 70. North America Cannabidiol Isolates Market Size, by Form, 2017-2032 (USD Million)
  • TABLE 71. North America Cannabidiol Isolates Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 72. North America Cannabidiol Isolates Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 73. North America Cannabidiol Isolates Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 74. North America Cannabidiol Isolates Market Size, by Extraction Method, 2017-2032 (USD Million)
  • TABLE 75. Latin America Cannabidiol Isolates Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 76. Latin America Cannabidiol Isolates Market Size, by Form, 2017-2032 (USD Million)
  • TABLE 77. Latin America Cannabidiol Isolates Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 78. Latin America Cannabidiol Isolates Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 79. Latin America Cannabidiol Isolates Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 80. Latin America Cannabidiol Isolates Market Size, by Extraction Method, 2017-2032 (USD Million)
  • TABLE 81. Europe Cannabidiol Isolates Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 82. Europe Cannabidiol Isolates Market Size, by Form, 2017-2032 (USD Million)
  • TABLE 83. Europe Cannabidiol Isolates Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 84. Europe Cannabidiol Isolates Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 85. Europe Cannabidiol Isolates Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 86. Europe Cannabidiol Isolates Market Size, by Extraction Method, 2017-2032 (USD Million)
  • TABLE 87. Middle East Cannabidiol Isolates Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 88. Middle East Cannabidiol Isolates Market Size, by Form, 2017-2032 (USD Million)
  • TABLE 89. Middle East Cannabidiol Isolates Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 90. Middle East Cannabidiol Isolates Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 91. Middle East Cannabidiol Isolates Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 92. Middle East Cannabidiol Isolates Market Size, by Extraction Method, 2017-2032 (USD Million)
  • TABLE 93. Africa Cannabidiol Isolates Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 94. Africa Cannabidiol Isolates Market Size, by Form, 2017-2032 (USD Million)
  • TABLE 95. Africa Cannabidiol Isolates Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 96. Africa Cannabidiol Isolates Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 97. Africa Cannabidiol Isolates Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 98. Africa Cannabidiol Isolates Market Size, by Extraction Method, 2017-2032 (USD Million)
  • TABLE 99. Global Cannabidiol Isolates Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 100. ASEAN Cannabidiol Isolates Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 101. ASEAN Cannabidiol Isolates Market Size, by Form, 2017-2032 (USD Million)
  • TABLE 102. ASEAN Cannabidiol Isolates Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 103. ASEAN Cannabidiol Isolates Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 104. ASEAN Cannabidiol Isolates Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 105. ASEAN Cannabidiol Isolates Market Size, by Extraction Method, 2017-2032 (USD Million)
  • TABLE 106. GCC Cannabidiol Isolates Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 107. GCC Cannabidiol Isolates Market Size, by Form, 2017-2032 (USD Million)
  • TABLE 108. GCC Cannabidiol Isolates Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 109. GCC Cannabidiol Isolates Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 110. GCC Cannabidiol Isolates Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 111. GCC Cannabidiol Isolates Market Size, by Extraction Method, 2017-2032 (USD Million)
  • TABLE 112. European Union Cannabidiol Isolates Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 113. European Union Cannabidiol Isolates Market Size, by Form, 2017-2032 (USD Million)
  • TABLE 114. European Union Cannabidiol Isolates Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 115. European Union Cannabidiol Isolates Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 116. European Union Cannabidiol Isolates Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 117. European Union Cannabidiol Isolates Market Size, by Extraction Method, 2017-2032 (USD Million)
  • TABLE 118. BRICS Cannabidiol Isolates Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 119. BRICS Cannabidiol Isolates Market Size, by Form, 2017-2032 (USD Million)
  • TABLE 120. BRICS Cannabidiol Isolates Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 121. BRICS Cannabidiol Isolates Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 122. BRICS Cannabidiol Isolates Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 123. BRICS Cannabidiol Isolates Market Size, by Extraction Method, 2017-2032 (USD Million)
  • TABLE 124. G7 Cannabidiol Isolates Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 125. G7 Cannabidiol Isolates Market Size, by Form, 2017-2032 (USD Million)
  • TABLE 126. G7 Cannabidiol Isolates Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 127. G7 Cannabidiol Isolates Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 128. G7 Cannabidiol Isolates Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 129. G7 Cannabidiol Isolates Market Size, by Extraction Method, 2017-2032 (USD Million)
  • TABLE 130. NATO Cannabidiol Isolates Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 131. NATO Cannabidiol Isolates Market Size, by Form, 2017-2032 (USD Million)
  • TABLE 132. NATO Cannabidiol Isolates Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 133. NATO Cannabidiol Isolates Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 134. NATO Cannabidiol Isolates Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 135. NATO Cannabidiol Isolates Market Size, by Extraction Method, 2017-2032 (USD Million)
  • TABLE 136. Global Cannabidiol Isolates Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 137. United States Cannabidiol Isolates Market Size, 2017-2032 (USD Million)
  • TABLE 138. United States Cannabidiol Isolates Market Size, by Form, 2017-2032 (USD Million)
  • TABLE 139. United States Cannabidiol Isolates Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 140. United States Cannabidiol Isolates Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 141. United States Cannabidiol Isolates Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 142. United States Cannabidiol Isolates Market Size, by Extraction Method, 2017-2032 (USD Million)
  • TABLE 143. Canada Cannabidiol Isolates Market Size, 2017-2032 (USD Million)
  • TABLE 144. Canada Cannabidiol Isolates Market Size, by Form, 2017-2032 (USD Million)
  • TABLE 145. Canada Cannabidiol Isolates Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 146. Canada Cannabidiol Isolates Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 147. Canada Cannabidiol Isolates Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 148. Canada Cannabidiol Isolates Market Size, by Extraction Method, 2017-2032 (USD Million)
  • TABLE 149. Mexico Cannabidiol Isolates Market Size, 2017-2032 (USD Million)
  • TABLE 150. Mexico Cannabidiol Isolates Market Size, by Form, 2017-2032 (USD Million)
  • TABLE 151. Mexico Cannabidiol Isolates Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 152. Mexico Cannabidiol Isolates Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 153. Mexico Cannabidiol Isolates Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 154. Mexico Cannabidiol Isolates Market Size, by Extraction Method, 2017-2032 (USD Million)
  • TABLE 155. Brazil Cannabidiol Isolates Market Size, 2017-2032 (USD Million)
  • TABLE 156. Brazil Cannabidiol Isolates Market Size, by Form, 2017-2032 (USD Million)
  • TABLE 157. Brazil Cannabidiol Isolates Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 158. Brazil Cannabidiol Isolates Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 159. Brazil Cannabidiol Isolates Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 160. Brazil Cannabidiol Isolates Market Size, by Extraction Method, 2017-2032 (USD Million)
  • TABLE 161. United Kingdom Cannabidiol Isolates Market Size, 2017-2032 (USD Million)
  • TABLE 162. United Kingdom Cannabidiol Isolates Market Size, by Form, 2017-2032 (USD Million)
  • TABLE 163. United Kingdom Cannabidiol Isolates Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 164. United Kingdom Cannabidiol Isolates Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 165. United Kingdom Cannabidiol Isolates Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 166. United Kingdom Cannabidiol Isolates Market Size, by Extraction Method, 2017-2032 (USD Million)
  • TABLE 167. Germany Cannabidiol Isolates Market Size, 2017-2032 (USD Million)
  • TABLE 168. Germany Cannabidiol Isolates Market Size, by Form, 2017-2032 (USD Million)
  • TABLE 169. Germany Cannabidiol Isolates Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 170. Germany Cannabidiol Isolates Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 171. Germany Cannabidiol Isolates Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 172. Germany Cannabidiol Isolates Market Size, by Extraction Method, 2017-2032 (USD Million)
  • TABLE 173. France Cannabidiol Isolates Market Size, 2017-2032 (USD Million)
  • TABLE 174. France Cannabidiol Isolates Market Size, by Form, 2017-2032 (USD Million)
  • TABLE 175. France Cannabidiol Isolates Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 176. France Cannabidiol Isolates Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 177. France Cannabidiol Isolates Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 178. France Cannabidiol Isolates Market Size, by Extraction Method, 2017-2032 (USD Million)
  • TABLE 179. Russia Cannabidiol Isolates Market Size, 2017-2032 (USD Million)
  • TABLE 180. Russia Cannabidiol Isolates Market Size, by Form, 2017-2032 (USD Million)
  • TABLE 181. Russia Cannabidiol Isolates Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 182. Russia Cannabidiol Isolates Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 183. Russia Cannabidiol Isolates Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 184. Russia Cannabidiol Isolates Market Size, by Extraction Method, 2017-2032 (USD Million)
  • TABLE 185. Italy Cannabidiol Isolates Market Size, 2017-2032 (USD Million)
  • TABLE 186. Italy Cannabidiol Isolates Market Size, by Form, 2017-2032 (USD Million)
  • TABLE 187. Italy Cannabidiol Isolates Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 188. Italy Cannabidiol Isolates Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 189. Italy Cannabidiol Isolates Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 190. Italy Cannabidiol Isolates Market Size, by Extraction Method, 2017-2032 (USD Million)
  • TABLE 191. Spain Cannabidiol Isolates Market Size, 2017-2032 (USD Million)
  • TABLE 192. Spain Cannabidiol Isolates Market Size, by Form, 2017-2032 (USD Million)
  • TABLE 193. Spain Cannabidiol Isolates Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 194. Spain Cannabidiol Isolates Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 195. Spain Cannabidiol Isolates Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 196. Spain Cannabidiol Isolates Market Size, by Extraction Method, 2017-2032 (USD Million)
  • TABLE 197. China Cannabidiol Isolates Market Size, 2017-2032 (USD Million)
  • TABLE 198. China Cannabidiol Isolates Market Size, by Form, 2017-2032 (USD Million)
  • TABLE 199. China Cannabidiol Isolates Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 200. China Cannabidiol Isolates Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 201. China Cannabidiol Isolates Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 202. China Cannabidiol Isolates Market Size, by Extraction Method, 2017-2032 (USD Million)
  • TABLE 203. India Cannabidiol Isolates Market Size, 2017-2032 (USD Million)
  • TABLE 204. India Cannabidiol Isolates Market Size, by Form, 2017-2032 (USD Million)
  • TABLE 205. India Cannabidiol Isolates Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 206. India Cannabidiol Isolates Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 207. India Cannabidiol Isolates Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 208. India Cannabidiol Isolates Market Size, by Extraction Method, 2017-2032 (USD Million)
  • TABLE 209. Japan Cannabidiol Isolates Market Size, 2017-2032 (USD Million)
  • TABLE 210. Japan Cannabidiol Isolates Market Size, by Form, 2017-2032 (USD Million)
  • TABLE 211. Japan Cannabidiol Isolates Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 212. Japan Cannabidiol Isolates Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 213. Japan Cannabidiol Isolates Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 214. Japan Cannabidiol Isolates Market Size, by Extraction Method, 2017-2032 (USD Million)
  • TABLE 215. Australia Cannabidiol Isolates Market Size, 2017-2032 (USD Million)
  • TABLE 216. Australia Cannabidiol Isolates Market Size, by Form, 2017-2032 (USD Million)
  • TABLE 217. Australia Cannabidiol Isolates Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 218. Australia Cannabidiol Isolates Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 219. Australia Cannabidiol Isolates Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 220. Australia Cannabidiol Isolates Market Size, by Extraction Method, 2017-2032 (USD Million)
  • TABLE 221. South Korea Cannabidiol Isolates Market Size, 2017-2032 (USD Million)
  • TABLE 222. South Korea Cannabidiol Isolates Market Size, by Form, 2017-2032 (USD Million)
  • TABLE 223. South Korea Cannabidiol Isolates Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 224. South Korea Cannabidiol Isolates Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 225. South Korea Cannabidiol Isolates Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 226. South Korea Cannabidiol Isolates Market Size, by Extraction Method, 2017-2032 (USD Million)
  • TABLE 227. Global Cannabidiol Isolates Market Share, by Key Player, 2025
  • TABLE 228. Global Cannabidiol Isolates Market, Key Experts